Page 88 - Read Online

Goodman et al. J Transl Genet Genom 2020;4:144-58 I http://dx.doi.org/10.20517/jtgg.2020.23 Page 157

Neurodevelopmental Disorders (POND) Network, in partnership with the Ontario Brain Institute
(OBI), and the Canadian Centre for Computational Genomics (C3G). Goodman SJ is supported by
The Lymphoma and Leukemia Society of Canada. Bioinformatic analyses were supported in part by the
Canadian Centre for Computational Genomics (C3G), part of the Genome Technology Platform (GTP),
funded by Genome Canada through Genome Quebec and Ontario Genomics (AL Turinsky, M Brudno),
and Genome Canada through Ontario Genomics (AL Turinsky, M Brudno and R Weksberg). Chung
BHY and Yeung KS are supported by the Health and Medical Research Fund and the Society of Relief for
Disabled Children of Hong Kong (SRDC).

Conflicts of interest
The authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Informed written consent to participate in the study was obtained from all research participants (or
parents/legal guardians for those under 16) according to the protocol approved by the Research Ethics
Board of the Hospital for Sick Children (REB# 1000038847).

Consent for publication
Not applicable.

Copyright
© The Author(s) 2020.

REFERENCES
1. Ho L, Crabtree GR. Chromatin remodelling during development. Nature 2010;463:474-84.
2. Bjornsson HT. The Mendelian disorders of the epigenetic machinery. Genome Res 2015;25:1473-81.
3. Smith ZD, Meissner A. DNA methylation: roles in mammalian development. Nat Rev Genet 2013;14:204-20.
4. Morgan HD, Santos F, Green K, Dean W, Reik W. Epigenetic reprogramming in mammals. Hum Mol Genet 2005;14:R47-58.
5. Numata S, Ye T, Hyde TM, Guitart-Navarro X, Tao R, et al. DNA methylation signatures in development and aging of the human
prefrontal cortex. Am j hum genet 2012;90:260-72.
6. Colantuoni C, Lipska BK, Ye T, Hyde TM, Tao R, et al. Temporal dynamics and genetic control of transcription in the human prefrontal
cortex. Nature 2011;478:519-23.
7. Tatton-Brown K, Loveday C, Yost S, Clarke M, Ramsay E, et al. Mutations in epigenetic regulation genes are a major cause of
overgrowth with intellectual disability. Am J Hum Genet 2017;100:725-36.
8. Fahrner JA, Bjornsson HT. Mendelian disorders of the epigenetic machinery: postnatal malleability and therapeutic prospects. Hum Mol
Genet 2019;28:R254-64.
9. Cytrynbaum C, Choufani S, Weksberg R. Epigenetic signatures in overgrowth syndromes: Translational opportunities. Am J Med Genet
A 2019;181:491-501.
10. Butcher DT, Cytrynbaum C, Turinsky AL, Siu MT, Inbar-Feigenberg M, et al. CHARGE and kabuki syndromes: gene-specific DNA
methylation signatures identify epigenetic mechanisms linking these clinically overlapping conditions. Am J Hum Genet 2017;100:773-88.
11. Chater-Diehl E, Ejaz R, Cytrynbaum C, Siu MT, Turinsky A, et al. New insights into DNA methylation signatures: SMARCA2 variants
in Nicolaides-Baraitser syndrome. BMC Med Genomics 2019;12:105.
12. Illingworth RS, Bird AP. CpG islands - ‘A rough guide’. FEBS Letters 2009;583:1713-20.
13. Torres IO, Fujimori DG. Functional coupling between writers, erasers and readers of histone and DNA methylation. Curr opin struct biol
2015;35:68-75.
14. Fuks F. DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev 2005;15:490-5.
15. Choufani S, Cytrynbaum C, Chung BH, Turinsky AL, Grafodatskaya D, et al. NSD1 mutations generate a genome-wide DNA
methylation signature. Nat Commun 2015;6:10207.
16. Aref-Eshghi E, Bend EG, Hood RL, Schenkel LC, Carere DA, et al. BAFopathies’ DNA methylation epi-signatures demonstrate
diagnostic utility and functional continuum of Coffin-Siris and Nicolaides-Baraitser syndromes. Nat Commun 2018;9:4885.
17. Aref-Eshghi E, Bend EG, Colaiacovo S, Caudle M, Chakrabarti R, et al. Diagnostic utility of genome-wide DNA methylation testing in
genetically unsolved individuals with suspected hereditary conditions. Am J Hum Genet 2019;104:685-700.
18. Kleefstra T. Disruption of the gene euchromatin histone methyl transferase1 (Eu-HMTase1) is associated with the 9q34 subtelomeric
deletion syndrome. J Med Genet 2005;42:299-306.